Bridel et al. demonstrated that mean CSF-ACE levels were not significantly different between neurosarcoidosis and non-neurosarcoidosis patients, and with a cut-off value of 2, the sensitivity and specificity of c-ACE were 66.7% and 67.3%, respectively [34]. This evidence concerns the gene ACE and neurosarcoidosis.